The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia

Ali Farrokhi,Tanmaya Atre,Jenna Rever,Mario Fidanza,Wendy Duey,Samuel Salitra,Junia Myung,Meiyun Guo,Sumin Jo,Anuli Uzozie,Fatemeh Baharvand,Nina Rolf,Franziska Auer,Julia Hauer,Stephan A. Grupp,Patrice Eydoux,Philipp F. Lange,Alix E. Seif,Christopher A. Maxwell,Gregor S. D. Reid

DOI: https://doi.org/10.1038/s41375-024-02221-x

2024-03-23

Leukemia

Abstract:The presence of supernumerary chromosomes is the only abnormality shared by all patients diagnosed with high-hyperdiploid B cell acute lymphoblastic leukemia (HD-ALL). Despite being the most frequently diagnosed pediatric leukemia, the lack of clonal molecular lesions and complete absence of appropriate experimental models have impeded the elucidation of HD-ALL leukemogenesis. Here, we report that for 23 leukemia samples isolated from moribund Eμ-Ret mice, all were characterized by non-random chromosomal gains, involving combinations of trisomy 9, 12, 14, 15, and 17. With a median gain of three chromosomes, leukemia emerged after a prolonged latency from a preleukemic B cell precursor cell population displaying more diverse aneuploidy. Transition from preleukemia to overt disease in Eμ-Ret mice is associated with acquisition of heterogeneous genomic abnormalities affecting the expression of genes implicated in pediatric B-ALL. The development of abnormal centrosomes in parallel with aneuploidy renders both preleukemic and leukemic cells sensitive to inhibitors of centrosome clustering, enabling targeted in vivo depletion of leukemia-propagating cells. This study reveals the Eμ-Ret mouse to be a novel tool for investigating HD-ALL leukemogenesis, including supervision and selection of preleukemic aneuploid clones by the immune system and identification of vulnerabilities that could be targeted to prevent relapse.

oncology,hematology

What problem does this paper attempt to address?

This paper mainly discusses a mouse model called E μ-Ret, which simulates the development of hyperdiploid B-cell precursor acute lymphoblastic leukemia (HD-ALL). HD-ALL is the most common type of leukemia in children and is characterized by nonrandom chromosomal gains. Although chromosomal abnormalities are relatively stable during disease progression, the study found diverse non-random chromosomal gains in leukemia samples from E μ-Ret mice, particularly trisomies of chromosomes 9, 12, 14, 15, and 17.

The study also showed that changes in gene expression and increased chromosomal instability accompany the progression from early abnormal B-cell precursor cells (preleukemic BCP) to leukemia. These abnormal cells are sensitive to centrosome clustering inhibitors, which may serve as a therapeutic strategy for preventing relapse. Furthermore, the E μ-Ret mouse model has proven to be a useful tool for studying the pathogenesis of HD-ALL, including the immunological selection and monitoring of preleukemic heterozygous clones, as well as the identification of vulnerabilities that can prevent relapse.

Through various experimental methods such as whole-genome sequencing, transcriptome analysis, and proteomics, the paper reveals the genetic evolution process of HD-ALL and indicates the presence of chromosomal abnormalities in the early stages of leukemia development, which are more concentrated in leukemia cells. These findings are important for understanding the pathogenic mechanisms of HD-ALL and identifying potential therapeutic targets.